AR3 MOXIFLOXACIN IV/PO MONOTHERAPY IS COST-EFFECTIVE TO THE GERMAN AND FRENCH HEALTHCARE SYSTEMS WHEN COMPARED TO IV/PO AMOXICILLIN/CLAVULANATE ± CLARITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA

✍ Scribed by M Drummond; D Becker; M Hux; J Chancellor; I Duprat-Lomon; PP Sagnier

• Book ID: 119591784
• Publisher: John Wiley and Sons
• Year: 2002
• Tongue: English
• Weight: 57 KB
• Volume: 5
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)60855-8